A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML

Clinical trial NCT03417427 · UNKNOWN

Trial details

NCT number: NCT03417427
Sponsor: Xuejie Jiang
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid

Start date: 2018-02-01
Primary completion: 2022-01-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.